PDL BioPharma, Inc. has named Andrew Guggenhime senior vice president and chief financial officer. Mr. Guggenhime will join the company’s senior management team reporting directly to chief executive officer Mark McDade, and will be responsible for all financial and information technology operations of the company. Mr. Guggenhime joins the company from Neoforma, Inc. where he had been chief financial officer since October 2000. In this role, he was responsible for the accounting, finan...